Record rise in people using private healthcare amid NHS frustration

Data prompts speculation NHS inability to cut waiting lists could make private healthcare ‘new normal’

Record numbers of people are paying for private healthcare, spending up to £3,200 on having a cataract removed and £15,075 on a new hip, amid growing frustration at NHS waiting lists.

Across the UK last year 272,000 people used their own funds to cover the cost of having an operation or diagnostic procedure at a private hospital. That was up from 262,000 the year before and a sharp rise on the 199,000 who did so in 2019, the year before the Covid pandemic struck.

Continue reading...

Pharmacist at former Sunak family chemist wary of PM’s health plans

Jithender Ballepu says more staff and funding would be needed and has concerns about passing antibiotics over the counter

There is no plaque outside Bassett Pharmacy in Southampton to indicate this was once run by the prime minister’s mother but there is a sign round the back that gives the game away: “Parking for Sunak Pharmacy customers.”

Inside, the pharmacist Jithender Ballepu was expressing reservations about Rishi Sunak’s plans for chemist shops to provide prescriptions for millions of patients in England.

Continue reading...

More than 7,000 nurses go on strike at two New York City hospitals

Nurses walked off the job at the Mount Sinai and Montefiore medical centers in Harlem and the Bronx over staffing issues

More than 7,000 nurses at two New York City hospitals went on strike on Monday, saying their concerns around staffing issues had not been addressed by management.

Talks failed on Sunday night. At 6am on Monday, nurses went on strike at Mount Sinai medical center on the Upper East Side and Montefiore medical center in the Bronx.

Continue reading...

FDA under fire over approval of Alzheimer’s drug Aduhelm

House of Representatives’ report details ‘corporate greed’ and ‘atypical review process’ preceding agency’s approval of Biogen’s drug

US drug regulators failed to follow their own guidance and practices when they approved the controversial Alzheimer’s drug Aduhelm, a congressional report said on Thursday.

The US food and drug administration’s (FDA) process of approval, it said, had been “rife with irregularities”, and the FDA’s interactions with maker Biogen had been “atypical”.

Continue reading...

Brexit red tape puts brakes on UK innovation and EU sales

Many new products now need multiple safety test facilities for home and abroad, say entrepreneurs

British inventions are being brought to market overseas because new Brexit safety certification rules mean they can’t be sold in the UK.

Trade bodies and entrepreneurs have blamed the government’s decision to stop accepting the European Union’s CE mark and instead create a new UK Conformity Assessed (UKCA) mark showing that a product is safe.

Continue reading...

MPs demand end to repayment clauses in contracts of overseas health workers

Employment conditions can tie staff to roles for up to five years and impose fees of £14,000 for an early return home

• Trapped and destitute: how foreign nurses’ dreams turned sour

The NHS must halt the use of “repayment clauses” in contracts for international healthcare workers, MPs have said.

Members of the Commons health and social care committee came to this finding after an Observer investigation in March revealed how some workers were being forced to pay thousands of pounds if they wish to quit their jobs before their agreed contract ends. Widely used in both the private health and social care sector and in the NHS, the clauses are designed to help with retention of workers and recouping costs associated with overseas recruitment.

Continue reading...

Amazon buys US medical provider as it cements move into healthcare

One Medical, the primary care organization, will be acquired by the e-commerce behemoth in a deal valued at roughly $3.9bn

Amazon will acquire the primary care organization One Medical in a deal valued roughly at $3.9bn, marking another expansion for the retailer into healthcare services.

The Seattle-based e-commerce giant said in a statement Thursday it is buying One Medical for $18 a share in an all-cash transaction. It’s one of Amazon’s biggest acquisitions, following its $13.7bn deal to buy Whole Foods in 2017 and its $8.5bn purchase of Hollywood studio MGM, which closed earlier this year.

Continue reading...

Shelf shock: soaring supermarket prices shoppers find hard to swallow

From dog food to coffee, readers are reporting some basic goods’ prices are rising by far more than inflation

Inflation is rampant, and supermarket prices are no exception. Shoppers are returning to stores to find old favourites have leapt in price from one week to the next. The cost of consumer goods is spiralling at such a rate that retail analysts have coined a new term, shelf shock.

Nestlé, the owner of KitKat, Häagen-Dazs and Felix cat food, became the latest consumer goods group to warn of more pain to come on Thursday, saying it had raised prices by 5.2% in the first three months of this year and that rising production costs would force another increase soon.

Continue reading...

GSK to buy US cancer drug developer amid pressure from activist investor

GlaxoSmithKline’s £1.5bn Sierra Oncology deal comes after pressure from Elliott to boost its pipeline

The UK drug company GlaxoSmithKline has agreed a £1.5bn deal to buy a US cancer treatment developer, Sierra Oncology, as it tries to fend off pressure from the activist shareholder Elliott Management.

The deal will give Britain’s second-largest pharmaceutical company access to California-based Sierra Oncology’s momelotinib, a drug being tested on anaemic patients with a type of bone marrow cancer called myelofibrosis. GSK said the drug had “significant growth potential” and it expected sales to start next year, with one analyst predicting it could generate peak annual sales of about $1.7bn (£1.3bn).

Continue reading...

Covid clinics: hope and high prices on the long road to recovery

Yoga, mud baths and liver compresses… Welcome to the world of luxury wellness and long Covid. Amelia Tait reports on the extreme wealth divide in the search for a cure

Underneath the shadow of the snow-topped Austrian Alps, in front of a forest of thick green trees and behind a pure azure lake, sits a sprawling chalet that has seen everyone from Kate Moss to Michael Gove pass through its wide glass doors. The VivaMayr health resort in Altaussee, Austria, has long been the picturesque home of celebrity detoxes – strict bans on caffeine and alcohol, combined with stricter rules about the number of times you need to chew your food (40, naturally) have helped numerous celebrity clientele lose weight. The detoxing might sound harsh, but tranquillity oozes through the resort’s Instagram page, where enchanting mists tickle thick evergreen trees and women pose with mugs in sleek, pine interiors. It’s not the image that comes to mind when you think “long-Covid clinic”, but it is one. For £2,700 a week (excluding accommodation), sufferers can attend VivaMayr’s post-Covid medical programme, which promises a “better quality of life”.

There is currently no cure for long Covid – the condition in which individuals continue to suffer Covid-19 symptoms for months after first being infected – but there are plenty of treatments. There is an entire network of specialist NHS long-Covid clinics across the United Kingdom – here, patients can undergo rehabilitative programmes to help them improve their stamina, breathing and cognitive functions (for many, long Covid is characterised by fatigue, breathlessness, and concentration problems). Yet in September, the Office for National Statistics estimated that 1.1 million people in the UK currently suffer with long Covid, while between July and August, only 5,737 people were referred to specialist NHS clinics. With the Omicron variant threatening more lives, there’s a gap in the market for long-Covid care, and plenty of private practitioners are happy to fill it – for a price.

Continue reading...

Randox: how one-man-band operation became a Covid testing giant

Healthcare firm named in Owen Paterson lobbying scandal has won £500m in UK government contracts

As the Covid-19 pandemic swept towards the UK, a senior employee of the healthcare firm Randox addressed an audience of horse racing royalty, gathered amid the neoclassical splendour of St George’s Hall in Liverpool.

Randox, which had garnered a role within the “sport of kings” via its sponsorship of the Grand National, had developed a test for Covid-19, he told them.

Continue reading...

Covid testing failures at UK lab ‘should have been flagged within days’

Senior scientists say problems at Immensa site show private firms should not be carrying out PCR tests

Health officials should have known about major failings at a private Covid testing lab within days of the problem arising, rather than taking weeks to shut down operations at the site, senior scientists say.

About 43,000 people, mostly in south-west England, are believed to have wrongly been told they did not have the virus by Immensa Health Clinic’s laboratory in Wolverhampton in a debacle described as one of the worst scandals in the UK’s Covid crisis.

Continue reading...

Oxygen firms accused of intimidating Mexican hospitals during pandemic

Hospitals received letters threatening large fines after they installed their own onsite O2 plants in response to shortages

In March 2020, Benjamin Espinoza Zavala saw an entire floor of his small hospital in Guanajuato, central Mexico, converted into Covid-19 wards. The hospital’s need for oxygen soared.

Deliveries from CryoInfra, part of the Grupo Infra group, occasionally slowed to once every couple of days, and he had to buy in extra to cover the sudden gaps in supply. Prices increased.

Continue reading...

Lloyds and HSBC are shedding office space … did they have too much to begin with?

Why there may be more to the announcement of Covid-inspired cuts than meets the eye

Here comes another bank that has decided, apparently definitively, that working practices will not return to their pre-pandemic norms. Lloyds Banking Group says it plans to shed 20% of its office space. Earlier this week, HSBC said it would get rid of 40%.

These figures are so dramatic that they invite suspicion. Have managements really come to the firm view that working from home is so popular that employees’ demands for flexibility must be granted? Or did these banks have too much office space in the first place and now wish to save a few quid?

Continue reading...

Fighting for breath: how the medical oxygen industry is failing African hospitals

Sub-Saharan hospitals are dependent on costly oxygen from multinational suppliers. As Covid-19 spreads, doctors are being forced to make terrible choices

As Covid-19 spreads throughout Africa, a potentially deadly lack of oxygen is leaving doctors unable to offer essential treatment.

Some experts put considerable blame on two multinational gas suppliers that dominate the market for oxygen cylinders across much of the continent, saying that their high prices and systems make the treatment unaffordable.

Continue reading...

Vitamin K could help fight coronavirus, study suggests

Scientists in Netherlands explore possible link between deficiency and Covid-19 deaths

Patients who have died or been admitted to intensive care with Covid-19 have been found to be deficient in a vitamin found in spinach, eggs and hard and blue cheeses, raising hopes that dietary change might be one part of the answer to combating the disease.

Researchers studying patients who were admitted to the Canisius Wilhelmina hospital in the Dutch city of Nijmegen have extolled the benefits of vitamin K after discovering a link between deficiency and the worst coronavirus outcomes.

Continue reading...

Scandal-hit NMC Health on verge of liquidation

Administrators outline position of UAE’s largest healthcare provider which faces multiple investigations

Joint administrators for NMC Health, the holding company of the UAE-based healthcare provider NMC Group, have said the company will probably be dissolved or put into liquidation.

Administrators from the consulting firm Alvarez & Marsal Europe were appointed in April to oversee the hospital operator, after an application from one of its biggest creditors, Abu Dhabi Commercial Bank.

Continue reading...

Revealed: NHS procurement official privately selling PPE amid Covid-19 outbreak

NHS launches inquiry after Guardian investigation exposes senior official trading protective gear amid pandemic

A head of procurement for the NHS has set up a business to profit from the private sale of huge quantities of personal protective equipment (PPE) in the midst of the coronavirus outbreak, an undercover investigation by the Guardian can reveal.

David Singleton, 42, a senior NHS official in London who has been working at the capital’s Covid-19 Nightingale hospital, launched the business two weeks ago to trade in visors, masks and gowns.

Continue reading...

Covid-19 could mark a deadly turn in Ghana’s fight against fake drugs

With substandard medicines already in wide circulation, fears are growing that coronavirus could create a lethal ‘parallel crisis’

When Joana Opoku-Darko’s daughter Anna was 18 months old, she came down with malaria, a disease common in Ghana and especially deadly for children.

She bought medication from a pharmacy in Ghana’s capital, Accra; when Anna’s fever didn’t subside she took her to a hospital, where they ran some tests.

Continue reading...

Blindsided: how coronavirus felled the global economy in 100 days

A singular event has economists asking the same questions as everyone else: how far is there to fall – and can we ever get back?

It is New Year’s Eve 2019 and around the world stock markets are closing for business on a high note. Shares in the US are up by almost 30% on the year, those in Japan by 18%. Even in Britain, where the mood has been dampened by months of Brexit uncertainty, the FTSE 100 has risen by 12%.

Overall, it had been the best year for stocks since 2009 and traders saw no real reason why the party should not continue into 2020. The US and China looked close to an armistice in their trade war, the US central bank was stimulating the world’s biggest economy, and Boris Johnson’s decisive victory in the general election had removed any lingering doubts about whether Britain would leave the European Union.

Continue reading...